Victory Capital Bid For Janus Henderson

Victory Capital bid for Janus Henderson is fully financed with lower client consent thresholds, heightening takeover pressure and reducing execution risk.

February 26, 2026·2 min read
View all news articles
Flat filled vector of a briefcase of sealed commitment letters symbolizing the Victory Capital bid for Janus Henderson.

KEY TAKEAWAYS

  • Victory Capital offered $57.04 per Janus Henderson share in a fully financed higher proposal.
  • The bid included committed debt, no financing condition, and pro forma 3.5x leverage excluding synergies.
  • Victory Capital projected $500 million in cost synergies and proposed lower client consent and fee terms.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Victory Capital Holdings (VCTR) submitted a fully financed bid for Janus Henderson Group (JHG) on February 26, 2026, offering $57.04 per share. The proposal asks JHG’s Special Committee to designate it a "Company Superior Proposal" under the existing merger agreement with Trian Fund Management.

Victory Capital Proposal and Terms Compared to Trian Deal

Victory Capital offered $57.04 per JHG share, consisting of $30 cash plus 0.350 VCTR shares based on VCTR’s closing price on February 25. The company described the offer as a 37.0% premium to JHG’s unaffected share price on October 24, 2025, and about 16.0% above Trian’s all-cash $49 bid announced December 22, 2025. Under the proposal, Janus shareholders would own roughly 38% of the combined company, which would have an implied enterprise value near $16.0 billion.

The bid is fully financed with cash on hand and committed debt from global investment banks, with commitment letters attached and no financing conditions. Victory Capital projected pro forma gross leverage of 3.5 times 2025 EBITDA excluding synergies and 2.6 times including estimated cost synergies of $500 million. This contrasts with the rival bidder’s roughly 4.6 times leverage. The synergies are expected from middle- and back-office efficiencies, vendor consolidation, and scale.

Victory Capital said the combined company would manage $323.2 billion in client assets (VCTR only, as of January 31, 2026) and intends to retain Janus Henderson investment professionals and the Janus Henderson brand under a revenue-share compensation model.

Janus Henderson’s existing merger agreement with Trian/General Catalyst commits to an all-cash $49 per-share transaction with an equity value of $7.4 billion. It requires 80.0% client consent and includes a 4.0% termination fee (about $297 million) and a reverse termination fee on financing failure (about $223 million), according to an 8-K filed February 26.

Victory Capital’s letter proposes lower closing conditions: a 75.0% client-consent threshold and a 3.0% termination fee. It seeks a full specific-performance remedy that removes financing outs and would not require payment from Janus Henderson if shareholders reject the proposal.

By emphasizing committed funding, the absence of financing conditions, a lower pro forma leverage profile, and projected cost synergies, Victory Capital frames its bid as offering a clearer execution path than the rival arrangement. This combination may increase pressure on Janus Henderson’s Special Committee to reconsider the sale.

Victory Capital noted this offer follows earlier proposals on November 24, December 8, and December 22, 2025, which it said generated no meaningful engagement from Janus Henderson.

"Victory Capital strongly believes that its proposal constitutes a 'Company Superior Proposal' under the Trian merger agreement due to its higher value and minimal execution risk," the company said in its February 26 letter.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Broadcom Earnings Preview AI Backlog Fuels Guidance

Broadcom Earnings Preview AI Backlog Fuels Guidance

Broadcom earnings preview focuses on AI-chip guidance and a $73.0 billion AI semiconductor backlog that will drive near-term trader positioning.

Theravance Biopharma CYPPRESS Misses Endpoint

Theravance Biopharma CYPPRESS Misses Endpoint

Theravance Biopharma CYPPRESS missed its primary endpoint, prompting a winddown, a sped-up strategic review and deep cost cuts that tighten cash runway.

Plug Power Q4 2025 Results Show Margin Turnaround

Plug Power Q4 2025 Results Show Margin Turnaround

Plug Power Q4 2025 results show revenue gains and its first positive gross margin, giving traders an execution signal amid liquidity and impairment risks.

Blackstone Private Credit Redemptions Reach Record

Blackstone Private Credit Redemptions Reach Record

Blackstone private credit redemptions signaled investor concern as BCRED met $3.8B withdrawals, testing fund liquidity and pressuring private-credit flows.

Apple M5 MacBook Launch Boosts AI Power

Apple M5 MacBook Launch Boosts AI Power

Apple M5 MacBook launch on March 3, 2026 delivers major AI and SSD gains, while reports of up to $400 price increases imply ASP and input-cost pressure.

Cigna CEO Appointment: Evanko to Succeed Cordani

Cigna CEO Appointment: Evanko to Succeed Cordani

Cigna CEO appointment Brian Evanko will become CEO on July 1, 2026 with Cordani moving to executive chair and guidance reaffirmed, signaling continuity.